Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.
Vaccine COVID Long COVID
About Vaccine COVID Long COVID
Studies suggested that COVID vaccination reduced the risk of long COVID, with estimates ranging from modest to around half. Long COVID, also called post COVID condition, has been estimated to affect 10 to 20 percent of COVID patients with symptoms lasting months including fatigue, brain fog, and shortness of breath. Vaccinated individuals who still contracted COVID were less likely to develop long COVID than unvaccinated individuals. The mechanism is unclear but may involve reduced viral load or immune modulation. Some long COVID patients reported improvement in symptoms after vaccination, suggesting persistent viral antigen may drive symptoms. The long COVID burden represents one of the most significant public health impacts of the pandemic. Some public health authorities cited possible long COVID prevention as an additional benefit of vaccination.
Related Entries
COVID-19 Pfizer
The Pfizer BioNTech COVID-19 vaccine was the first mRNA vaccine authorized for emergency use, grante...
COVID-19 Moderna
The Moderna COVID-19 vaccine was developed in collaboration with the National Institute of Allergy a...
COVID-19 Johnson
The Johnson and Johnson COVID-19 vaccine used a modified adenovirus vector,different from the mRNA v...
COVID-19 AstraZeneca
The Oxford AstraZeneca COVID-19 vaccine was developed by scientists at the University of Oxford Jenn...